Launch Readiness June 7, 2022 Best Practices: Identifying and Avoiding Patient Access Barriers 4 Minute Read Market access leaders from DBV Technologies, Sesen Bio, and Karyopharm Therapeutics discuss strategies to overcome obstacles to patient initiation and adherence.
Launch Readiness March 24, 2022 Best Practices: Achieving Your Pre-Launch Sales Forecasts 6 Minute Read Market access leaders from DBV Technologies, Karyopharm Therapeutics, and Sesen Bio discuss critical factors in a successful launch and ways to achieve pre-launch forecasts.
Managed Services July 27, 2018 The Economics of Rare Disease and Implications for Payer Contract Strategy 3 Minute Read Rare diseases affect 30 million people in the United States, which roughly equates to 10% of the population. In 2017, 40% of the novel drugs approved by the FDA...
